PRAME expression in head and neck cancer correlates with markers of poor prognosis and might help in selecting candidates for retinoid chemoprevention in pre-malignant lesions
Keywords: PRAME, Preferentially Expressed Antigen in Melanoma; RA, retinoic acid; RAR, retinoic acid receptor; HNSCC, head and neck squamous cell carcinoma; TAA, tumor associated antigens; ALDH, aldehyde dehydrogenase; RT-PCR, reverse transcription polymerase chain